Our study indicated that there existed an obvious trend of better OS in ChRT over ExRT for HPV-positive HNSCC patients, but no significant difference was observed here.
← all excerpts
Comparative efficacy and safety of radiotherapy/cetuximab <i>versus</i> radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data.
1
—
—